Nitrite is an alternative source of NO in vivo

1 Department of Pharmacology and 2 Department of Pediatrics, The University of Tokushima School of Medicine, and 3 Department of Clinical Pharmacology and 4 Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan Submitted 2...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Heart and circulatory physiology Vol. 288; no. 5; pp. H2163 - H2170
Main Authors Tsuchiya, Koichiro, Kanematsu, Yasuhisa, Yoshizumi, Masanori, Ohnishi, Hideki, Kirima, Kazuyoshi, Izawa, Yuki, Shikishima, Michiyo, Ishida, Tatsuhiro, Kondo, Shuji, Kagami, Shoji, Takiguchi, Yoshiharu, Tamaki, Toshiaki
Format Journal Article
LanguageEnglish
Published United States 01.05.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Department of Pharmacology and 2 Department of Pediatrics, The University of Tokushima School of Medicine, and 3 Department of Clinical Pharmacology and 4 Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan Submitted 2 June 2004 ; accepted in final form 22 December 2004 In this study, we investigated whether orally administered nitrite is changed to NO and whether nitrite attenuates hypertension in a dose-dependent manner. We utilized a stable isotope of [ 15 N]nitrite ( 15 NO 2 – ) as a source of nitrite to distinguish between endogenous nitrite and that exogenously administered and measured hemoglobin (Hb)-NO as an index of circulating NO in whole blood using electron paramagnetic resonance (EPR) spectroscopy. When 1 mg/kg Na 15 NO 2 was orally administered to rats, an apparent EPR signal derived from Hb 15 NO ( A Z = 23.4 gauss) appeared in the blood. The peak blood HbNO concentration occurred at the first measurement after intake (5 min) for treatment with 1 and 3 mg/kg (HbNO: 4.93 ± 0.52 and 10.58 ± 0.40 µM, respectively) and at 15 min with 10 mg/kg (HbNO: 38.27 ± 9.23 µM). In addition, coadministration of nitrite (100 mg/l drinking water) with N -nitro- L -arginine methyl ester ( L -NAME; 1 g/l) for 3 wk significantly attenuated the L -NAME-induced hypertension (149 ± 10 mmHg) compared with L -NAME alone (170 ± 13 mmHg). Furthermore, this phenomenon was associated with an increase in circulating HbNO. Our findings clearly indicate that orally ingested nitrite can be an alternative to L -arginine as a source of NO in vivo and may explain, at least in part, the mechanism of the nitrite/nitrate-rich Dietary Approaches to Stop Hypertension diet-induced hypotensive effects. nitric oxide; hypertension; electron paramagnetic resonance Address for reprint requests and other correspondence: T. Tamaki, Dept. of Pharmacology, The Univ. of Tokushima School of Medicine, Tokushima 770-8503, Japan (E-mail: tamaki{at}basic.med.tokushima-u.ac.jp )
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00525.2004